Cargando…

Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2

Background: Due to the extreme infectivity of SARS-CoV-2, sample-to-answer SARS-CoV-2 reverse transcription (RT) polymerase chain reaction (PCR) assays are urgently needed in order to facilitate infectious disease surveillance and control. The purpose of this study was to evaluate three sample-to-an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Joonhong, Kim, So Yeon, Lee, Jaehyeon, Hong, Ki Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859140/ https://www.ncbi.nlm.nih.gov/pubmed/36672974 http://dx.doi.org/10.3390/genes14010233

Ejemplares similares

Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2
por: Creager, Hannah M., et al.
Publicado: (2020)

Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection
por: Liotti, Flora Marzia, et al.
Publicado: (2020)

BioFire FilmArray respiratory panel RP2.1 for SARS-CoV-2 detection: The pitfalls
por: Chang, Yu-Chang, et al.
Publicado: (2022)

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay
por: Graham, Maryza, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)

Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage
por: Phan, Tung, et al.
Publicado: (2022)

1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
por: Strength, Rachel, et al.
Publicado: (2021)

Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test
por: Mostafa, Heba H., et al.
Publicado: (2021)

Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples
por: Berry, Gregory J., et al.
Publicado: (2022)

Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples
por: Eckbo, Eric J., et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens
por: Hou, Hongyan, et al.
Publicado: (2020)

634. Head-to Head Comparison of the Performance of BIOFIRE(®) SPOTFIRE(®) Respiratory/Sore throat Panel, Cepheid Xpert(®) Xpress SARS-CoV-2/Flu/RSV and Cobas(®) SARS-CoV-2 & Influenza A/B Assay for Detection of Respiratory Viruses
por: Banerjee, Dithi, et al.
Publicado: (2023)

Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay
por: Isles, Nicole, et al.
Publicado: (2022)

Comparative Performance Evaluation of FilmArray BioFire RP2.1 and MAScIR 2.0 Assays for SARS-CoV-2 Detection
por: Tazi, Sophia, et al.
Publicado: (2022)

Understanding false positives and the detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and BD MAX SARS-CoV-2 assays
por: Navarathna, Dhammika H., et al.
Publicado: (2021)

Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2
por: McCormick-Baw, Clare, et al.
Publicado: (2020)

Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic
por: Wolters, Femke, et al.
Publicado: (2020)

Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
por: Malczynski, Michael, et al.
Publicado: (2020)

Validation of the Cepheid Xpert® Xpress SARS-CoV-2 using upper and lower respiratory tract specimens
por: Rong, Kassie, et al.
Publicado: (2022)

Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2
por: Cassidy, Hayley, et al.
Publicado: (2022)

Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel
por: Kim, Tae Yeul, et al.
Publicado: (2022)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Presumptive positive with the Cepheid Xpert Xpress SARS-CoV-2 assay due to N mutations in the Delta variant
por: Choi, Hosoon, et al.
Publicado: (2022)

A four specimen-pooling scheme reliably detects SARS-CoV-2 and influenza viruses using the BioFire FilmArray Respiratory Panel 2.1
por: Ranadheera, Charlene, et al.
Publicado: (2022)

The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
por: Quicke, Kendra M., et al.
Publicado: (2022)

701. Rapid Detection of Antimicrobial Resistance Determinants with the BioFire(®) System
por: Marxreiter, Stefanie, et al.
Publicado: (2018)

Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections
por: Peri, Anna Maria, et al.
Publicado: (2022)

Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test
por: Sluimer, John, et al.
Publicado: (2021)

Evaluation of the automated cartridge-based ARIES SARS-CoV-2 Assay (RUO) against automated Cepheid Xpert Xpress SARS-CoV-2 PCR as gold standard
por: TANIDA, KONSTANTIN, et al.
Publicado: (2020)

Evaluation of the BioFire Gastrointestinal Panel to Detect Diarrheal Pathogens in Pediatric Patients
por: Jo, Sung Jin, et al.
Publicado: (2021)

Respiratory coinfections in COVID-19 patients evaluated by BioFire Pneumonia Panel
por: Assal, Hebatallah Hany, et al.
Publicado: (2021)

2072. Clinical Evaluation of the BioFire® Global Fever Special Pathogens Panel
por: Collins, Brittany, et al.
Publicado: (2023)

Comparison of the Clinical Performance of the Point-of-care STANDARD M10 SARS-CoV-2 and Xpert Xpress SARS-CoV-2 Assays
por: Hong, Ki Ho, et al.
Publicado: (2023)

Usefulness of BioFire FilmArray BCID2 for Blood Culture Processing in Clinical Practice
por: Berinson, Benjamin, et al.
Publicado: (2021)

876. Suggested Empiric Therapy for CoNS Identified by BioFire BCID2 – Making Mountains Out of Molehills?
por: Ryu, HaYoung, et al.
Publicado: (2022)

Rapid Evaluation of the Xpert(®) Xpress CoV-2 plus and Xpert(®) Xpress CoV-2/Flu/RSV plus Tests
por: Noble, Lara Dominique, et al.
Publicado: (2022)

300. Pediatric Center Evaluation of the BioFire(®) Blood Culture Identification 2 Panel Versus the Original BioFire(®)FilmArray(®) Blood Culture Identification Panel for the Detection of Microorganisms and Resistance Markers in Positive Blood Cultures
por: Pierce, Kristina B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vounubmm60s323buqu5mbj8ld9